Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Invested Capital (2020 - 2025)

iSpecimen has reported Invested Capital over the past 6 years, most recently at $3.1 million for Q4 2025.

  • Quarterly results put Invested Capital at $3.1 million for Q4 2025, down 6.73% from a year ago — trailing twelve months through Dec 2025 was $3.1 million (down 6.73% YoY), and the annual figure for FY2025 was $3.1 million, down 6.73%.
  • Invested Capital for Q4 2025 was $3.1 million at iSpecimen, up from $3.1 million in the prior quarter.
  • Over the last five years, Invested Capital for ISPC hit a ceiling of $29.8 million in Q4 2021 and a floor of -$31.2 million in Q1 2021.
  • Median Invested Capital over the past 5 years was $10.9 million (2021), compared with a mean of $10.2 million.
  • Biggest five-year swings in Invested Capital: soared 231.31% in 2021 and later tumbled 89.79% in 2025.
  • iSpecimen's Invested Capital stood at $29.8 million in 2021, then tumbled by 31.83% to $20.3 million in 2022, then plummeted by 52.04% to $9.7 million in 2023, then tumbled by 66.01% to $3.3 million in 2024, then dropped by 6.73% to $3.1 million in 2025.
  • The last three reported values for Invested Capital were $3.1 million (Q4 2025), $3.1 million (Q3 2025), and $621973.0 (Q2 2025) per Business Quant data.